Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Experic
AddedFeb 15, 2024
UpdatedJun 18, 2026
Experic

Experic

Series B

Experic, a CDMO, offers end-to-end pharmaceutical supply services, from clinical to commercial scale, with global delivery.

HQ
Cranbury, NJ, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Experic is a contract development and manufacturing organization (CDMO) specializing in pharmaceutical supply services. The company supports every stage of a product's life cycle, from clinical to commercial scale, offering a variety of dosing and packaging formats such as capsule filling, powder and pellet dosing, and autoinjectors. Experic leverages cutting-edge Harro Höfliger equipment to ensure the highest quality products and manages global delivery, even for expedited projects.

Experic has established itself as a leader in pharmaceutical development, clinical trial supply, and specialized commercial drug manufacturing. Known for its expertise in inhalation products, the company provides timely access to resources and experts to expedite product development and clinical trial supplies. This commitment to excellence has made Experic a trusted partner in the pharmaceutical industry, significantly impacting the efficiency and quality of drug manufacturing and delivery.

Experic - Similar Companies

Societal Cdmo logo

Societal Cdmo

societalcdmo.com

Incog Biopharma Services logo

Incog Biopharma Services

incogbiopharma.com

Selkirk Pharma logo

Selkirk Pharma

selkirkpharma.com

August Bioservices logo

August Bioservices

augustbio.com

Havix Group logo

Havix Group

Sharp Services logo

Sharp Services

sharpservices.com

Phlow logo

Phlow

phlow-usa.com

Catalent logo

Catalent

catalent.com

Innovex logo

Innovex

Andersonbrecon logo

Andersonbrecon

West Pharmaceutical Services I logo

West Pharmaceutical Services I

westpharma.com

Quintiles logo

Quintiles

quintiles.com

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Endpoint Clinical logo

Endpoint Clinical

Apertus Pharmaceuticals logo

Apertus Pharmaceuticals

Experic - Quick Facts

Who are Experic's competitors?

Companies similar to Experic include Societal Cdmo, Incog Biopharma Services, Selkirk Pharma and August Bioservices.

When was Experic founded?

Experic was founded in 2015.

Where is Experic's headquarters located?

Experic's headquarters is located in Cranbury, NJ, US.

How much has Experic raised to-date?

As of Oct 5, 2023, Experic has raised a total of $14M (USD).

How many employees does Experic have?

Experic has 51 employees as of Feb 4, 2024.

Experic - Classification

Industry
  • Professional Service Companies
Technology
  • Manufacturing
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Pharmaceutical Services
Tags
  • Biotech
  • Pharma
NAICS
  • 330000Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries